CHF 78.00

Round Cell Tumors
Highly aggressive group of malignant tumors.. DE

English · Paperback / Softback

Shipping usually within 2 to 3 weeks

This item cannot be returned.

Description

Read more

Most frequent Round Cell Tumors are Non-Hodgkins Lymphoma, Neuroblastoma, Ewing/PNET and Rhabdomyosarcoma. Neuroblastoma, Retinoblastoma, Wilms Tumor, Hepatoblastoma show presentation in early childhood while Rhabdomyosarcoma is seen throughout childhood. The majority of round cells tumors have male predominance. Identification and accurate diagnosis of a tumor is an art and necessiates complete knowledge of cellular, biochemical , molecular events and pathogenesis of the tumor. Round cell tumors are characterised by round and relatively undifferentiated cell. Differential diagnosis of round cell tumors is difficult due to their undifferentiated or primitive character, those tumors that shows good differentiation are generally easy to diagnose .The ubiquitous distribution and diverse histology of different round cell tumors pose a challenge in their diagnosis. The diagnostic aids like the use of special stain, immunocytochemistry, flowcytometric, immunophenotyping, and reverse-transcriptase polymerase chain reaction are extremely useful in cases when tumors are undifferentiated and distinction is not possible on morphological basis alone.

Product details

Authors Veena Kumar, Ashish Chandra, Navin Kumar
Publisher LAP Lambert Academic Publishing
 
Content Book
Product form Paperback / Softback
Publication date 14.03.2023
Subject Natural sciences, medicine, IT, technology > Medicine > Dentistry
 
EAN 9786205633557
ISBN 9786205633557
Pages 104
Dimensions (packing) 15 x 22 cm
 

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.